SYSMEX PARTEC GMBH – Trademark Portfolio

Entity Type: 16

SYSMEX PARTEC GMBH holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 10 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include ROBBY, PARTEC, CYSCOPE, and CELLTRICS. The owner is based in GOERLITZ.

AM FLUGPLATZ 13

GOERLITZ 02828 , DE

10 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

SYSMEX PARTEC GMBH's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (10 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (5 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does SYSMEX PARTEC GMBH have?

SYSMEX PARTEC GMBH has 10 U.S. trademarks filed with the USPTO. Of these, 4 registered.

What trademark classes does SYSMEX PARTEC GMBH file in?

SYSMEX PARTEC GMBH files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are SYSMEX PARTEC GMBH's most well-known trademarks?

SYSMEX PARTEC GMBH's registered trademark portfolio includes well-known marks such as ROBBY, PARTEC, CYSCOPE, and CELLTRICS. These are among 4 currently registered trademarks in the portfolio.

What is SYSMEX PARTEC GMBH's trademark registration success rate?

SYSMEX PARTEC GMBH has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.